S&P 500 7,443 -0.96% Nasdaq 25,508 -1.41% Dow Jones 51,839 -1.26% FTSE 100 10,525 +0.25% DAX 24,847 -1.07% Nikkei 225 65,256 -3.67% Hang Seng 25,012 +2.76% WTI Crude 82.18 +3.24% Gold 4,046 +0.06% US 10-Year Treasury Yield 4.598 +0.28% S&P 500 7,443 -0.96% Nasdaq 25,508 -1.41% Dow Jones 51,839 -1.26% FTSE 100 10,525 +0.25% DAX 24,847 -1.07% Nikkei 225 65,256 -3.67% Hang Seng 25,012 +2.76% WTI Crude 82.18 +3.24% Gold 4,046 +0.06% US 10-Year Treasury Yield 4.598 +0.28%

LATEST

Q1 results 2026: Bajaj Auto to Adani Energy among companies to declare Q1 results today; full list here●Binance & OKX users face $1900 fines in Vietnam, Coinbase in China? Asia Express●SEC charges Florida man and company in alleged $22 million crypto mining fraud scheme●Ships shun Strait of Hormuz as renewed fighting strains key oil corridor●Exide Industries: can its lithium-ion bet drive returns over the next 3 years?●HKEX to allow confidential filings, lower market cap threshold for start-ups, sources say●Stocks to watch: Bajaj Auto, Adani Energy, Paytm among shares in focus today; check list here●Gold gains as hopes for US-Iran diplomacy cool oil price rally●Q1 results 2026: Bajaj Auto to Adani Energy among companies to declare Q1 results today; full list here●Binance & OKX users face $1900 fines in Vietnam, Coinbase in China? Asia Express●SEC charges Florida man and company in alleged $22 million crypto mining fraud scheme●Ships shun Strait of Hormuz as renewed fighting strains key oil corridor●Exide Industries: can its lithium-ion bet drive returns over the next 3 years?●HKEX to allow confidential filings, lower market cap threshold for start-ups, sources say●Stocks to watch: Bajaj Auto, Adani Energy, Paytm among shares in focus today; check list here●Gold gains as hopes for US-Iran diplomacy cool oil price rally●

Front Page

The FDA’s peptide vote could create telehealth's next multibillion-dollar market

fm-term-meta-233910339-mutual-fund | FORTUNE · 15h ago

The FDA’s peptide vote could create telehealth's next multibillion-dollar market

As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.

Read the full story at fm-term-meta-233910339-mutual-fund | FORTUNE →

More Front Page

Ships shun Strait of Hormuz as renewed fighting strains key oil corridor

US Top News and Analysis · 47m ago

TikTok Live Shopping Fuels Rapid Revenue Growth for UK SMBs

EUROS · 4h ago

Jamie Dimon says markets underestimate risks and he wouldn't buy stocks or Treasurys at current prices

US Top News and Analysis · 4h ago

US hits Canada with 50% tariffs, invoking 1930 trade act

EUROS · 4h ago